Perineural invasion and spread in head and neck cancer

Expert Review of Anticancer Therapy

Volumn 12, Issue 3, 2012, Pages 359-371

  Johnston, Meredith ^a   Yu, Eugene ^b   Kim, John ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

H N cancer; image guided radiation therapy (IGRT); intensity modulated radiation therapy (IMRT); MRI; perineural invasion; perineural spread; radiation therapy

Indexed keywords

CETUXIMAB; CISPLATIN;

ASPERGILLOSIS; BELL PALSY; CANCER INVASION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; FACIAL NERVE; FACIAL NERVE SURGERY; HEAD AND NECK CANCER; HUMAN; IMAGE GUIDED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; LIQUORRHEA; MANDIBULAR NERVE; MAXILLARY NERVE; METASTASIS; MUCORMYCOSIS; NERVE TUMOR; NEURITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION DOSE FRACTIONATION; RECURRENCE RISK; REVIEW; SALIVARY GLAND CANCER; SQUAMOUS CELL CARCINOMA; STROKE; TRIGEMINAL NERVE; TRIGEMINUS NEURALGIA;

CARCINOMA; DISEASE MANAGEMENT; HEAD AND NECK NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; MUCOUS MEMBRANE; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NERVOUS SYSTEM NEOPLASMS; PARANASAL SINUSES; PERIPHERAL NERVES; RADIOTHERAPY, IMAGE-GUIDED; STOMATOGNATHIC SYSTEM; TECHNOLOGY, RADIOLOGIC;

EID: 84863276641     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/era.12.9     Document Type: Review

References (70)

1. Ginsberg L. Imaging of perineural tumor spread in head and neck cancer. In:Head and Neck Imaging. Som P, Hugh D (Eds). MO, USA, 865-886 (2003).
2. Barrett AW, Speight PM. Perineural invasion in adenoid cystic carcinoma of the salivary glands: A valid prognostic indicator? Oral Oncol. 45(11), 936-940 (2009).
3. Ginsberg LE. Imaging of perineural tumor spread in head and neck cancer. Semin. Ultrasound CT MR 20(3), 175-186 (1999).
4. Liebig C, Ayala G, Wilks JA, Berger DH, Albo D. Perineural invasion in cancer: A review of the literature. Cancer 115(15), 3379-3391 (2009).
5. Soo KC, Carter RL, O'Brien CJ, Barr L, Bliss JM, Shaw HJ. Prognostic implications of perineural spread in squamous carcinomas of the head and neck. Laryngoscope 96(10), 1145-1148 (1986).
6. Vural E, Hutcheson J, Korourian S, Kechelava S, Hanna E. Correlation of neural cell adhesion molecules with perineural spread of squamous cell carcinoma of the head and neck. Otolaryngol. Head Neck Surg. 122(5), 717-720 (2000).
7. Nemec SF, Herneth AM, Czerny C. Perineural tumor spread in malignant head and neck tumors. Top. Magn. Reson. Imaging 18(6), 467-471 (2007).
8. Carter RL, Foster CS, Dinsdale EA, Pittam MR. Perineural spread by squamous carcinomas of the head and neck: A morphological study using antiaxonal and antimyelin monoclonal antibodies. J. Clin. Pathol. 36(3), 269-275 (1983).
9. Fagan JJ, Collins B, Barnes L, D'Amico F, Myers EN, Johnson JT. Perineural invasion in squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg. 124(6), 637-640 (1998).
10. Kurtz KA, Hoffman HT, Zimmerman MB, Robinson RA. Perineural and vascular invasion in oral cavity squamous carcinoma: Increased incidence on re-review of slides and by using immunohistochemical enhancement. Arch. Pathol. Lab. Med. 129(3), 354-359 (2005).
11. Guzzo M, Di Palma S, Grandi C, Molinari R. Salivary duct carcinoma: Clinical characteristics and treatment strategies. Head Neck 19(2), 126-133 (1997).
12. Nabili V, Tan JW, Bhuta S, Sercarz JA, Head CS. Salivary duct carcinoma: A clinical and histologic review with implications for trastuzumab therapy. Head Neck 29(10), 907-912 (2007).
13. Chong VF, Fan YF, Khoo JB. Nasopharyngeal carcinoma with intracranial spread: CT and MR characteristics. J. Comput. Assist. Tomogr. 20(4), 563-569 (1996).
14. Chong VF, Fan YF. Hypoglossal nerve palsy in nasopharyngeal carcinoma. Eur. Radiol. 8(6), 939-945 (1998).
15. Schmalfuss IM, Tart RP, Mukherji S, Mancuso AA. Perineural tumor spread along the auriculotemporal nerve. AJNR Am. J. Neuroradiol. 23(2), 303-311 (2002).
16. College of American Pathologists. Cancer Protocols and Checklists. IL, USA (2009).
17. Caldemeyer KS, Mathews VP, Righi PD, Smith RR. Imaging features and clinical significance of perineural spread or extension of head and neck tumors. Radiographics 18(1), 97-110; quiz 147 (1998).
18. Brandwein-Gensler M, Teixeira MS, Lewis CM et al. Oral squamous cell carcinoma: Histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am. J. Surg. Pathol. 29(2), 167-178 (2005).
19. Chang PC, Fischbein NJ, McCalmont TH et al. Perineural spread of malignant melanoma of the head and neck: Clinical and imaging features. AJNR Am. J. Neuroradiol. 25(1), 5-11 (2004).
20. Parker GD, Harnsberger HR. Clinical-radiologic issues in perineural tumor spread of malignant diseases of the extracranial head and neck. Radiographics 11(3), 383-399 (1991).
21. Batsakis JG. Nerves and neurotropic carcinomas. Ann. Otol. Rhinol. Laryngol. 94(4 Pt 1), 426-427 (1985).
22. Kolokythas A, Cox DP, Dekker N, Schmidt BL. Nerve growth factor and tyrosine kinase A receptor in oral squamous cell carcinoma: Is there an association with perineural invasion? J. Oral. Maxillofac. Surg. 68(6), 1290-1295 (2010).
23. Solares CA, Brown I, Boyle GM, Parsons PG, Panizza B. Neural cell adhesion molecule expression: No correlation with perineural invasion in cutaneous squamous cell carcinoma of the head and neck. Head Neck 31(6), 802-806 (2009).
24. Akert K, Sandri C, Weibel ER, Peper K, Moor H. The fine structure of the perineural endothelium. Cell Tissue Res. 165(3), 281-295 (1976).
25. Nemzek WR, Hecht S, Gandour-Edwards R, Donald P, McKennan K. Perineural spread of head and neck tumors: How accurate is MR imaging? AJNR Am. J. Neuroradiol. 19(4), 701-706 (1998).
26. Ojiri H. Perineural spread in head and neck malignancies. Radiat. Med. 24(1), 1-8 (2006).
27. Yu E, O'Sullivan B, Kim J, Siu L, Bartlett E. Magnetic resonance imaging of nasopharyngeal carcinoma. Expert Rev. Anticancer Ther. 10(3), 365-375 (2010).
28. Catalano PJ, Sen C, Biller HF. Cranial neuropathy secondary to perineural spread of cutaneous malignancies. Am. J. Otol. 16(6), 772-777 (1995).
29. Gandhi D, Gujar S, Mukherji SK. Magnetic resonance imaging of perineural spread of head and neck malignancies. Top. Magn. Reson. Imaging 15(2), 79-85 (2004).
30. Curtin HD. Detection of perineural spread: Fat suppression versus no fat suppression. AJNR Am. J. Neuroradiol. 25(1), 1-3 (2004).
31. Binmadi NO, Basile JR. Perineural invasion in oral squamous cell carcinoma: A discussion of significance and review of the literature. Oral Oncol. 47(11), 1005-1010 (2011).
32. Woolgar JA. Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol. 42(3), 229-239 (2006).
33. Tai SK, Li WY, Chu PY et al. Risks and clinical implications of perineural invasion in T1-2 oral tongue squamous cell carcinoma. Head Neck doi:10.1002/hed.21846 (2011) (Epub ahead of print).
34. Hinerman RW, Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Villaret DB. Postoperative irradiation for squamous cell carcinoma of the oral cavity: 35-year experience. Head Neck 26(11), 984-994 (2004).
35. Parsons JT, Mendenhall WM, Stringer SP, Cassisi NJ, Million RR. An analysis of factors influencing the outcome of postoperative irradiation for squamous cell carcinoma of the oral cavity. Int. J. Radiat. Oncol. Biol. Phys. 39(1), 137-148 (1997).
36. Gonzalez-Garcia R, Naval-Gias L, Roman-Romero L, Sastre-Perez J, Rodriguez-Campo FJ. Local recurrences and second primary tumors from squamous cell carcinoma of the oral cavity: A retrospective analytic study of 500 patients. Head Neck 31(9), 1168-1180 (2009).
37. Liao CT, Chang JT, Wang HM et al. Does adjuvant radiation therapy improve outcomes in pT1-3N0 oral cavity cancer with tumor-free margins and perineural invasion? Int. J. Radiat. Oncol. Biol. Phys. 71(2), 371-376 (2008).
38. Langendijk JA, Slotman BJ, van der Waal I, Doornaert P, Berkof J, Leemans CR. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy. Cancer 104(7), 1408-1417 (2005).
39. Bernier J, Domenge C, Ozsahin M et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N. Engl. J. Med. 350(19), 1945-1952 (2004).
40. Bernier J, Cooper JS, Pajak TF et al. Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck 27(10), 843-850 (2005).
41. Cooper JS, Pajak TF, Forastiere AA et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 350(19), 1937-1944 (2004).
42. Ang KK, Trotti A, Brown BW et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 51(3), 571-578 (2001).
43. Rosenthal DI, Liu L, Lee JH et al. Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck. Head Neck 24(2), 115-126 (2002).
44. Gomez DR, Katabi N, Zhung J et al. Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland. Cancer 115(10), 2128-2137 (2009).
45. Spiro RH. Distant metastasis in adenoid cystic carcinoma of salivary origin. Am. J. Surg. 174(5), 495-498 (1997).
46. Garden AS, Weber RS, Morrison WH, Ang KK, Peters LJ. The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation. Int. J. Radiat. Oncol. Biol. Phys. 32(3), 619-626 (1995).
47. Chen AM, Garcia J, Granchi P, Bucci MK, Lee NY. Base of skull recurrences after treatment of salivary gland cancer with perineural invasion reduced by postoperative radiotherapy. Clin. Otolaryngol. 34(6), 539-545 (2009).
48. Gomez DR, Hoppe BS, Wolden SL et al. Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: A recent experience. Int. J. Radiat. Oncol. Biol. Phys. 70(5), 1365-1372 (2008).
49. Terhaard CH, Lubsen H, Rasch CR et al. The role of radiotherapy in the treatment of malignant salivary gland tumors. Int. J. Radiat. Oncol. Biol. Phys. 61(1), 103-111 (2005).
50. Pogodzinski MS, Sabri AN, Lewis JE, Olsen KD. Retrospective study and review of polymorphous low-grade adenocarcinoma. Laryngoscope 116(12), 2145-2149 (2006).
51. Schwarz S, Muller M, Ettl T, Stockmann P, Zenk J, Agaimy A. Morphological heterogeneity of oral salivary gland carcinomas: A clinicopathologic study of 41 cases with long term follow-up emphasizing the overlapping spectrum of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma. Int. J. Clin. Exp. Pathol. 4(4), 336-348 (2011).
52. Seethala RR, Johnson JT, Barnes EL, Myers EN. Polymorphous low-grade adenocarcinoma: The University of Pittsburgh experience. Arch. Otolaryngol. Head Neck Surg. 136(4), 385-392 (2010).
53. Johnston M, Waldron J, Huang S et al. Salivary duct carcinoma: Treatment, outcomes and clinico-pathological review. Int. J. Radiat. Oncol. Biol. Phys. 81(2 Suppl.), S526 (2011) (Abstract 2658).
54. Sobin LH. UICC TNM Classification of Malignant Tumours. Sobin LH, Gospodarowicz MK, Wittekind C (Eds). Wiley-Blackwell, NJ, USA (2010).
55. Edge S, Byrd D. AJCC Cancer Staging Manual. Edge S, Byrd D (Eds). Springer, NY, USA (2010).
56. Dean NR, White HN, Carter DS et al. Outcomes following temporal bone resection. Laryngoscope 120(8), 1516-1522 (2010).
57. Mohan R, Wu Q, Wang X, Stein J. Intensity modulation optimization, lateral transport of radiation, and margins. Med. Phys. 23(12), 2011-2021 (1996).
58. Kim JJ, Tannock IF. Repopulation of cancer cells during therapy: An important cause of treatment failure. Nat. Rev. Cancer 5(7), 516-525 (2005).
59. ICRU Report 50: Prescribing, recording, and reporting photon beam therapy. In: International Commission on Radiation Units and Measurements. MD, USA (1993).
60. ICRU Report 62: Prescribing, recording, and reporting photon beam therapy. In: International Commission on Radiation Units and Measurements. MD, USA (1999).
61. ICRU 83: Definition of volumes. In: Journal of the ICRU. Oxford University Press, UK, 41-53 (2010).
62. Brahme A. Optimization of stationary and moving beam radiation therapy techniques. Radiother. Oncol. 12(2), 129-140 (1988).
63. Gustafsson A, Lind BK, Brahme A. A generalized pencil beam algorithm for optimization of radiation therapy. Med. Phys. 21(3), 343-356 (1994).
64. Soderstrom S, Gustafsson A, Brahme A. The clinical value of different treatment objectives and degrees of freedom in radiation therapy optimization. Radiother. Oncol. 29(2), 148-163 (1993).
65. Yu CX, Amies CJ, Svatos M. Planning and delivery of intensity-modulated radiation therapy. Med. Phys. 35(12), 5233-5241 (2008).
66. Dogan N, Leybovich LB, King S, Sethi A, Emami B. Improvement of treatment plans developed with intensity-modulated radiation therapy for concave-shaped head and neck tumors. Radiology 223(1), 57-64 (2002).
67. Kim J, Meyer J, Dawson L. IGRT and the New Practice of Radiotherapy. In:Front Radiat Ther Oncol. What to Know and Use from a Decade of Investigation in IMRT-IGRT-SBRT: Advances in the Treatment Planning and Deliver of Radiotherapy. Meyer J (Ed.). Karger, Basel, Switzerland (2011).
68. Jaffray D, Bissonnette J-P, Craig T. X-ray Imaging for Verification and Localization in Radiation Therapy. Van Dyk J (Ed.). Medical Physics Publishing, WI, USA (2005).
69. van Herk M, Remeijer P, Rasch C, Lebesque JV. The probability of correct target dosage: Dose-population histograms for deriving treatment margins in radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 47(4), 1121-1135 (2000).
70. Zeidan OA, Langen KM, Meeks SL et al. Evaluation of image-guidance protocols in the treatment of head and neck cancers. Int. J. Radiat. Oncol. Biol. Phys. 67(3), 670-677 (2007).